2.500EUR+0.40%Mkt Cap: —P/E: —1d ago
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value12.44M $
Revenue (TTM)14.81M $
Gross Profit12.21M $
Net Income (TTM)-7.26M $
Revenue/Share2.443 USD
Last Price2.500 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees69
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-18.06
EV/Revenue0.84
P/S—
P/B0.89
EPS (TTM)—
EPS (Forward)—
52W Range
2.490100% of range2.500
52W High2.500 EUR
52W Low2.490 EUR
Profitability
Gross Margin82.41%
Oper. Margin0.24%
EBITDA Margin-4.65%
Profit Margin-17.92%
ROE-36.44%
ROA-1.96%
Growth
Revenue Growth13.40%
Earnings Growth227.30%
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-4.07M $
Net Debt/EBITDA5.91
Balance Sheet
Debt/Equity11.05
Current Ratio2.96
Quick Ratio2.07
Book Value/Sh2.813 EUR
Cash/Share0.9280 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float1.40M
Insiders27.00%
Institutions0.00%
Technical
SMA 50—
SMA 200—
Beta-0.23
S&P 52W Chg18.16%
Avg Vol (30d)2
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—